APA (7th ed.) Citation

Turkes, F., Bryant, A., Begum, R., Davidson, M., Kalaitzaki, E., Aresu, M., . . . Chau, I. (2022). Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study. Current Oncology, 29(4), 2174. https://doi.org/10.3390/curroncol29040176

Chicago Style (17th ed.) Citation

Turkes, Fiona, et al. "Ibrutinib in C-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept IMYC Study." Current Oncology 29, no. 4 (2022): 2174. https://doi.org/10.3390/curroncol29040176.

MLA (9th ed.) Citation

Turkes, Fiona, et al. "Ibrutinib in C-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept IMYC Study." Current Oncology, vol. 29, no. 4, 2022, p. 2174, https://doi.org/10.3390/curroncol29040176.